The overarching goal of the Biostatistics Shared Resource (BSR) within the Chao Family ComprehensiveCancer Center (CFCCC) is to provide statistical and intellectual support to all CFCCC investigators at allphases of scientific projects. The mission of the BSR faculty and staff is to be intimately involved in theconception, design, implementation, analysis, and reporting of research conducted by members of the CFCCC.While the majority of effort from BSR faculty is devoted to providing collaboration and service to CFCCCinvestigators the BSR also encourages the development of statistical methodologic research that relatesdirectly to the scientific agenda and needs of CFCCC investigators. The BSR is staffed by six PhD levelstatisticians and one MS level statistician. Dr. Daniel Gillen, Professor of Statistics with affiliate appointments inthe Department of Epidemiology and the Program in Public Health, serves as the Director of the BSR. Dr.Michael Phelan serves as the BSR Facilities Manager. Drs. Christine McLaren, Kathryn Osann, ThomasTaylor, and Chad Garner all hold faculty appointments at UC Irvine. The faculty and staff of the BSR haveparticular expertise in multiple areas of statistical methodology with applications to cancer research, makingthem an invaluable resource for CFCCC members and key contributors to the overall research mission of theCancer Center. Examples of the many services provided by the BSR include collaboration on study design,data analysis, and interpretation, development of research protocols and grant proposals, assistance withdatabase design and linkage of clinical, epidemiologic, and laboratory data, statistical expertise for CFCCCoversight committees, and education, training, and mentoring of CFCCC members.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA062203-20
Application #
9208761
Study Section
Subcommittee A - Cancer Centers (NCI-A)
Project Start
Project End
Budget Start
2017-02-01
Budget End
2018-01-31
Support Year
20
Fiscal Year
2017
Total Cost
$65,745
Indirect Cost
$23,192
Name
University of California Irvine
Department
Type
Domestic Higher Education
DUNS #
046705849
City
Irvine
State
CA
Country
United States
Zip Code
92617
Chakraborty, Mahul; VanKuren, Nicholas W; Zhao, Roy et al. (2018) Hidden genetic variation shapes the structure of functional elements in Drosophila. Nat Genet 50:20-25
Morozko, Eva L; Ochaba, Joseph; Hernandez, Sarah J et al. (2018) Longitudinal Biochemical Assay Analysis of Mutant Huntingtin Exon 1 Protein in R6/2 Mice. J Huntingtons Dis 7:321-335
Carpenter, Philip M; Ziogas, Argyrios; Markham, Emma M et al. (2018) Laminin 332 expression and prognosis in breast cancer. Hum Pathol 82:289-296
Yan, Huaming; Romero-López, Mónica; Benitez, Lesly I et al. (2018) Multiscale modeling of glioblastoma. Transl Cancer Res 7:S96-S98
Yu, James; Landberg, Jenny; Shavarebi, Farbod et al. (2018) Bioengineering triacetic acid lactone production in Yarrowia lipolytica for pogostone synthesis. Biotechnol Bioeng 115:2383-2388
Oliver, Andrew; Kay, Matthew; Cooper, Kerry K (2018) Comparative genomics of cocci-shaped Sporosarcina strains with diverse spatial isolation. BMC Genomics 19:310
Mahlbacher, Grace; Curtis, Louis T; Lowengrub, John et al. (2018) Mathematical modeling of tumor-associated macrophage interactions with the cancer microenvironment. J Immunother Cancer 6:10
Neek, Medea; Tucker, Jo Anne; Kim, Tae Il et al. (2018) Co-delivery of human cancer-testis antigens with adjuvant in protein nanoparticles induces higher cell-mediated immune responses. Biomaterials 156:194-203
McLelland, Bryce T; Lin, Bin; Mathur, Anuradha et al. (2018) Transplanted hESC-Derived Retina Organoid Sheets Differentiate, Integrate, and Improve Visual Function in Retinal Degenerate Rats. Invest Ophthalmol Vis Sci 59:2586-2603
Bota, Daniela A; Chung, Jinah; Dandekar, Manisha et al. (2018) Phase II study of ERC1671 plus bevacizumab versus bevacizumab plus placebo in recurrent glioblastoma: interim results and correlations with CD4+ T-lymphocyte counts. CNS Oncol 7:CNS22

Showing the most recent 10 out of 1106 publications